Intelliject’s novel epinephrine auto-injector, E-cue™, receives tentative FDA Approval for Anaphylaxis
According to Intelliject, Inc., allergic reactions including anaphylaxis will now receive emergency treatments thanks to the US-FDA approval of the
Read more